Edwards Lifesciences (EW) Current Assets (2009 - 2026)

Edwards Lifesciences has reported Current Assets for 18 years, with the latest figure at $6.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Current Assets changed 0.26% year-over-year to $6.2 billion; the trailing twelve-month figure through Mar 2026 stood at $6.2 billion (changed 0.26% YoY), and the FY2025 full-year result was $6.7 billion, up 7.22% from the prior year.
• Current Assets for Q1 2026 stood at $6.2 billion, down from $6.7 billion in the prior quarter.
• The five-year high for Current Assets was $6.7 billion in Q4 2025, with the low at $3.1 billion in Q4 2022.
• Average Current Assets over 5 years is $4.8 billion, with a median of $4.2 billion recorded in 2024.
• Year-over-year, Current Assets surged 65.4% in 2024 and slipped 5.48% in 2025.
• Tracing EW's Current Assets over 5 years: stood at $3.1 billion in 2022, then surged by 30.36% to $4.0 billion in 2023, then surged by 55.74% to $6.3 billion in 2024, then grew by 7.22% to $6.7 billion in 2025, then declined by 7.57% to $6.2 billion in 2026.
• The last three Current Assets figures came in at $6.2 billion (Q1 2026), $6.7 billion (Q4 2025), and $6.4 billion (Q3 2025), per Business Quant data.

Peer Comparison